欢迎来到《四川大学学报(医学版)》 2025年3月31日 星期一

基于基因芯片技术的人乳头瘤病毒分型检测方法及应用评价

和晓利, 刘洪倩, 何斌, 杨沛, 王和, 刘珊玲

和晓利, 刘洪倩, 何斌, 等. 基于基因芯片技术的人乳头瘤病毒分型检测方法及应用评价[J]. 四川大学学报(医学版), 2013, 44(4): 641-645.
引用本文: 和晓利, 刘洪倩, 何斌, 等. 基于基因芯片技术的人乳头瘤病毒分型检测方法及应用评价[J]. 四川大学学报(医学版), 2013, 44(4): 641-645.
HE Xiao-li, LIU Hong-qian, HE Bin, et al. The Use of Human Papillomavirus Genotying Kit Based on Gene Chip Technology for Detecting and Typing of Human Papillomavirus[J]. Journal of Sichuan University (Medical Sciences), 2013, 44(4): 641-645.
Citation: HE Xiao-li, LIU Hong-qian, HE Bin, et al. The Use of Human Papillomavirus Genotying Kit Based on Gene Chip Technology for Detecting and Typing of Human Papillomavirus[J]. Journal of Sichuan University (Medical Sciences), 2013, 44(4): 641-645.

栏目: 技术与方法

基于基因芯片技术的人乳头瘤病毒分型检测方法及应用评价

基金项目: 

国家自然科学基金(No.30772323)和四川省科技厅科技支撑计划(No.2012SZ0136)资助

The Use of Human Papillomavirus Genotying Kit Based on Gene Chip Technology for Detecting and Typing of Human Papillomavirus

  • [1] 苏韵华, 许丹, 张玉泉. 宫颈癌及癌前病变多种筛查方法的研究进展.实用妇产科杂志,2009;25(9):529-530.
    [2]

    Kjr SK, van den Brule AJC, Bock JE, et al. Human papillomavirus-the most significant risk determinant of cervical intraepithelial neoplasia.Int J Cancer,1996;65(5):601-606.

    [3]

    Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol,1999;189(1):12-19.

    [4]

    Wright TC Jr, Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.Obstet Gynecol,2004;103(2):304-309.

    [5]

    Spitzer M. Cervical screening adjuncts:recent advances.Am J Obstet Gynecol,1998;179(2):544-556.

    [6]

    Tadokoro K, Akutsu Y, Tanaka K, et al. Comparative quantitative analysis of 14 types of human papillomavirus by real-time polymerase chain reaction monitoring Invader reaction (Q-Invader assay).Diagn Microbiol Infect Dis,2010;66(1):58-64.

    [7]

    Jones J, Powell Ng, Tristram A, et al. Comparison of the PapilloCheck® DNA micro-array Human Papillomavirus detection assay with Hybrid Capture Ⅱ and PCR-enzyme immunoassay using the GP5/6+ primer set.J Clin Virol,2009;45(2):100-104.

    [8]

    Damasus-Awatai G, Freeman-Wang T. Human papilloma virus and cervical screening. Curr Opin Obstet Gynecol,2003;15(16):473-477.

    [9]

    Castle PE, Schiffman M, Burk,RD, et al. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.Cancer Epidemiol Biomarkers Prev,2002;11(11):1394-1399.

    [10]

    Muoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer.N Engl J Med,2003;348(6):518-527.

    [11]

    Bosch FX, Manos MM, Muñoz N, et al. Prevalence of human papillomavirus in cervical cancer:a worldwide perspective.J Nat Cancer Institute,1995;87(11):796-802.

    [12]

    Hong D, Ye F, Chen H, et al. Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province, China.Int J Gynecol Cancer,2008;18(1):104-109.

    [13]

    Nielsen A, Kjaer SK, Munk C, et al Type-specific HPV infection and multiple HPV types:prevalence and risk factor profile in nearly 12,000 younger and older Danish women.Sex Transm Dis,2008;35(3):276-282.

    [14]

    Bachtiary B, Obermair A, Dreier B, et al. Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer. Int J Cancer,2002;102(3):237-243.

    [15]

    Bosch FX, Lorincz A, Muñoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol,2002;55(4):244-265.

计量
  • 文章访问数:  3328
  • HTML全文浏览量:  157
  • PDF下载量:  33
  • 被引次数: 0
出版历程
  • 收稿日期:  2012-12-16
  • 修回日期:  2013-04-10
  • 发布日期:  2013-07-19

目录

    /

    返回文章
    返回